Zealand Pharma — Februar 2024
-
(Der snakkes om fedmemedicin og selskaber i videoen).
-
Hen - Tak for sat ind link, som virker.
-
YPE - Fremskrivninger af den slags kan være meget vanskelig. Kommer der 1, 2 eller 3 indikationer osv.
-
Gubra har flere kandidater mod vægttab - nævnes som muligt opkøbsmål https://www.proinvestor.com/investornyt/1112539/gubra-har-flere-kandidater-mod-vaegttab-naevnes-som-muligt-opkobsmal
-
Og Gubra har flere samarbejdsaftaler med BI. Jeg har tænkt at både BI og ZP kunne se på dem som opkøbskandidat.
-
Der er i øvrigt øget yderligere på short. Nu er vi gået op fra 3,79% til 3,83%. Men som Buffet siger - det gode med short er at de skal købe aktierne tilbake.
-
De må vel regne med at den falder på et tidspunkt. Dårlige nyheder eller hvad der nu kan ske.
-
Men i dag er den fulgt med Novo op:-)
-
489 op 4.75% outstanding
-
Ja, hver gang den lige sætter sig lidt, bliver den hevet lynhurtigt op igen. Imponerende underliggende styrke, og mon ikke snart 500 skal testes, hvis der ikke kommer dårlige nyheder.
Styrken i aktien kunne ihvertfald indikere, at der er mere at hente i Zeal Vi får se -
"
Currently, we are looking for a new Medical Director (Obesity), with an extensive track record of success in Medical Affairs in the area of metabolism. If this sounds like you, and you are ready to take on a broad area of responsibilities with an independent attitude, you are a match for us". https://apps.hrmeasy.dk/zeal/hrmeasy_recruitment_zealand.nsf/0/007EBD971D0704FAC1258AB700468566?opendocument -
Currently, we are looking for a new Sr. Director of New Product Planning (NPP), who has 10-15 years of prior Commercial experience leading across multiple functions with complementary expertise in early-stage commercialization and US/EU market access. Ideal background also includes experience at a top VC-like investor or as part of the Business Development or New Product Planning team in a biotech company....https://apps.hrmeasy.dk/zeal/hrmeasy_recruitment_zealand.nsf/0/3BEA4B863F9236E3C1258AB70
-
Ovenstående er blot to af flere stillingsopslag fra Zealand Pharma pt.
-
Tak YPE.
-
Shortpositioner på danske aktier https://oam.finanstilsynet.dk/#!/stats-and-extracts-short-net-positions
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind